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In contrast to cold blooded vertebrates, the ability to regenerate morphologically and 
functionally complex structures is limited in adult mammals. Recruitment of progenitor cells 
is a key step in the regenerative process. The possibility of repairing missing or diseased 
tissues in humans has been potentiated by the increasing understanding of somatic stem cells, 
their plasticity and the possibility of modulating it, that could be harnessed either to stimulate 
endogenous repair or engineer the required tissue. Here we focus on human mesenchymal 
stem cells (MSCs), important players in tissue homeostasis in healthy organisms, with a 
particular emphasis on those derived from the adipose tissue (ADSCs). While a mark of MSC 
identity is the ability to differentiate into osteoblasts, chondrocytes, and adipocytes, there is 
evidence that their potential goes beyond these three mesenchymal lineages. We discuss some 
differentiation and modulatory properties of MSCs and provide an overview of our recent 
work on ADSCs from paediatric patients (pADSCs) that has shown their ability to give raise 
to non-mesenchymal cells, consistent with a significant plasticity. Finally, we present novel 
data indicating that both mesenchymal lineages (adipogenic, chondrogenic and osteogenic) 
and neural and epithelial lineages can originate from clonal lines that like the parental line 
express markers of pluripotency as well as the stromal cell marker, GREM1. Together these 






The possibility of regenerating entire organs has fascinated humankind for centuries given the 
limited regenerative ability in humans in contrast to extraordinary regenerative capabilities 
observed in certain species where entire body structures can be fully replaced. For example, 
cold blooded vertebrates, such as fish and amphibians, can regenerate limbs, jaws, tails, heart, 
and even their nervous system, spontaneously (Berg et al., 2010, Ferretti and Géraudie, 1998, 
Goss, 1969, Slack, 2017, Spallanzani, 1768, Stocum, 2006, Tzahor and Poss, 2017). 
Regeneration occurs via formation of a mound of undifferentiated progenitor cells, the 
blastema, in response to injury. The mechanisms underlying mobilization of these cells, their 
origin and differentiation potential has been a matter of much debate for several decades, and 
obviously depends on the tissue/organ to be replaced and the species studied (Godwin, 2014, 
Zielins et al., 2016). 
 
Recruitment of progenitor cells is a key step in the regenerative process and the ability to 
stimulate it in mammals represents a potential strategy for inducing regeneration in humans, 
as exemplified by studies on mammalian digit tip regeneration (Agrawal et al., 2010, Simkin 
et al., 2015). Furthermore, a crucial role of inflammatory responses in stimulating 
regeneration in several species has emerged over the last few years, with a key role for 
inflammatory cells demonstrated following digit tip amputation and regeneration of the skin 
in the African spiny mouse (Godwin, 2014, Simkin et al., 2017). Another approach to 
circumvent the limited regenerative ability in mammals is the use of autologous or allogeneic 
cells to engineer tissue for reconstructing structures damaged by injury, disease or birth 
defects. Whichever approach one might wish to take to improve repair of human tissues, a 
thorough understanding of developmental mechanisms leading to formation of the structure of 
interest in vivo and of the potential for repair of human progenitor cells, both pre- and post-
natally, is crucial. Investigation of mechanisms governing development, cellular plasticity, 
and normal and abnormal function of human tissues is hampered by the very limited 
possibility of experimental manipulations of human tissues in vivo. Hence, most of our 
understanding of cellular and molecular mechanisms governing human development and 
repair is either extrapolated from animal studies, that do not always reflect human cell 
behavior or disease presentation, or in vitro systems. 
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Among human tissues with very limited regenerative capability are the bone and cartilages of 
the craniofacial skeleton. In fact, while skeletal fracture healing is a fairly efficient process, in 
humans critical size skeletal defects are not spontaneously repaired.  This is in contrast to 
salamander and fish ability to fully regenerate their jaws, in addition to their appendicular 
skeleton, upon recruitment of mesenchymal progenitor cells to form the blastema (Ghosh et 
al., 1996, Paul et al., 2016).  Hence mesenchymal cells are key players in the regenerative 
process, but humans do not seem able to effectively activate them to repair large skeletal 
defects.  
 
Consequently, widely investigated cell types for developing novel treatment modalities for 
craniofacial defects in humans are Mesenchymal Stem Cells (MSCs). Since the discovery of 
MSCs in the human bone marrow in 1968 (Friedenstein et al., 1968) there has been an ever-
increasing interest in these cells.  MSCs are known to be important for tissue homeostasis, but 
cannot regenerate missing bone or cartilage in humans. Therefore, much focus has been on 
their potential use in cell-based therapies for repairing damaged tissue, which has resulted in 
hundreds of current and planned clinical trials (Squillaro et al., 2016). The interest in using 
MSCs to repair these tissues has obviously generated a huge number of papers on their 
characterization, and raised a number of questions about the specific identity and properties of 
MSCs from different tissues and their plasticity. 
 
In depth discussion of the huge wealth of studies and of differences between human MSCs 
from different tissues is beyond the purpose of this article. Here we will briefly discuss some 
properties and origin of MSCs with a particular focus on those derived from adipose tissue 
(ADSCs), and provide an overview of our recent published work on ADSCs from paediatric 
patients (pADSCs) in the context of current knowledge. We will also discuss novel data 
supporting pADSC plasticity and their ability to give raise to non-mesenchymal cells. 
 
Mesenchymal stem cell (MSC) properties and origin 
 
MSCs are multipotent stem cells with high capacity for self-renewal and expansion; they are 
endowed with differentiation potential to various lines, including, but as we will discuss later 
not limited to, osteoblasts, chondrocytes, and adipocytes. They can be found virtually in all 
tissues and are believed to reside mainly within the perivascular niche. 
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MSCs are routinely isolated as the so-called “stromal fraction” from the vast majority of 
human tissues (Fig. 1), both adult and paediatric, as well as from extra-embryonic tissues 
(umbilical cord, placenta and amniotic fluid) (Stubbendorff et al., 2013). 
 
Post-natally, common sources of MSCs are the bone marrow, adipose tissue and dental pulp. 
MSCs have been characterized extensively after culture in vitro; however, this procedure 
selects cells on their ability to adhere to plastic surfaces or other substrates, as well as to 
expand after adhesion; therefore the resulting cell population may display some different 
features from the native stromal fraction it was derived from. A set of cell surface markers is 
used to characterize MSCs, usually by flow cytometry; although some of these markers, as 
exemplified in Table 1, are common to MSCs derived from diverse sources, differences in the 
expression of others have been described. These differences reflect features of the tissue of 
origin and culture conditions (Hass et al., 2011, New et al., 2015). Furthermore expression of 
“MSC” surface markers seems to be shared also by other somatic stem cells, calling for 
caution on classifying cells as MSC only on the basis of these markers (New et al., 2015).   
  
 
Somatic stem cells had not been classically considered to be highly plastic, but the plasticity 
of human MSCs is now well documented, though much variation between studies is noted; 
this is likely due to differences in experimental conditions, individual donors genetic 
background, or a combination of the two (Hass et al., 2011, Ullah et al., 2015). While a 
general definition of MSCs is based on their 3 mesenchymal lineage differentiation potential 
(cartilage, bone and adipose), it has been proposed that they harbor also myogenic capability 
(Rodriguez et al., 2006, Stern-Straeter et al., 2014, Szaraz et al., 2017). In addition, cells of 
non-mesodermal lineages, such as hepatocytes, endothelial, epithelial, pancreatic and neural 
cells have also been derived from MSCs using specific cocktails of cytokines and chemical 
compounds (Bekhite et al., 2014, New et al., 2017, Ullah et al., 2015). Furthermore, MSCs 
have been reprogramed to Inducible Pluripotent Stem Cells (IPSCs) using pluripotency 
transcription factors, or reprogrammed to directly generate specific tissue types through 
forced expression of lineage-specific transcription factors (Hynes et al., 2016). Overall, MSCs 
from different sources seems to share the property of  being more easily reprogrammed than 
mature somatic cells, such as fibroblast and blood cells; this appears to correlate with 
expression, though at low levels, of pluripotency transcription factors (Galende et al., 2010, 
Guasti et al., 2012, Streckfuss-Bomeke et al., 2013, Sun et al., 2009).  
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Despite the comprehensive characterization of MSCs properties in vitro, much less is known 
regarding their exact location in the tissues of origin and their precise role in the regulation of 
tissue homeostasis.  A better understanding of these two aspects would certainly facilitate the 
exploitation of their translational potential. Several recent independent studies have shown 
that cells with MSCs properties can be localized in and isolated from perivascular locations in 
the tissues of origin (Murray and Peault, 2015); however, MSCs not associated with the 
vasculature have been identified in certain structures, such as cranial sutures (Zhao et al., 
2015). The MSCs associated with the vasculature, the so called Perivascular Stem Cells 
(PSCs), are seemingly pericytes and adventitial cells, and appear to contribute to local tissue 
repair upon activation in response to injury (Crisan et al., 2008, da Silva Meirelles et al., 
2015). PSCs, like all MSCs studied, display an important property, which is 
immunomodulation; in fact they have been shown to secrete discreet set of cytokines as well 
as activate T suppressor lymphocytes, resulting in a complex immunosurveillance during the 
repair process (Blanco et al., 2016, Gebler et al., 2012, Melief et al., 2013). This potent 
immunomodulatory role is indeed being harnessed in clinical trials aimed, for example, at 
ameliorating graft versus host disease, improving allogenic stem cell transplants or function in 
diseased liver and kidney (Gao et al., 2016, Squillaro et al., 2016). However, evidence for a 
significant role of grafted cells in tissue regeneration has yet to be provided.  
 
As it has become more and more apparent that beneficial effects of MSCs are mediated via 
paracrine mechanisms, there has been much interest in defining the secretome of these cells as 
well as identifying approaches to activating/mobilizing them in the hope of developing cell-
free therapies and harness any endogenous regenerative potential (Embree et al., 2016, Mele 
et al., 2016, Miller and Kaplan, 2012). The initial focus has been on growth factors and 
cytokines, but a cocktail of MSC-secreted growth factors and cytokine that mimic closely the 
effect of injected MSCs has yet to be defined (Toh et al., 2017). More recently, the 
therapeutic potential of MSC-derived exosomes has come to the forefront. Exosomes are 30-
150 nm secreted vesicles that carry proteins, nucleic acids (e.g. microRNAs) and lipids and 
are now believed to play key functions in cell-cell communications both at short and long 
range (Thomou et al., 2017). Recent studies reporting beneficial effect of adipose stem cell 
exosomes in a range of animal disease models, including skin wound healing, 
revascularization, amyotropic lateral sclerosis and myocardial ischemia, are galvanizing 
interest in exploiting their properties to develop novel therapeutic approaches (Cui et al., 
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2017, Hu et al., 2016, Kang et al., 2016, Lee et al., 2016). Furthermore, the ability of MSC to 
exchange materials at a shorter range via tunnelling nanotubes has also been suggested 
(Vignais et al., 2017). 
 
Finally, it has been recently shown that stem cells expressing typical MSC surface markers 
are present in fibrocartilage and that modulation of Wnt signaling plays an important role in 
the maintenance of this cell pool. Significantly, in vivo treatment with a Wnt inhibitor, 
sclerostin, induced cartilage formation and aided repair in an injured temporomandibular joint 
(Embree et al., 2016). While the possibility of stimulating endogenous MSCs for tissue repair 
in humans is still in its infancy, this study provides proof of principle that by better 
understanding basic mechanism modulating tissue homeostasis it will be possible to develop 
minimally invasive effective treatments.  
 
Adipose tissue and adipose tissue-derived stem cells 
 
The human ADSCs most commonly studied are derived from white adipose tissue (WAT), 
whose function is to store fuel while acting as a proper endocrine organ by secreting leptin 
and adiponectin, two key energy homeostasis regulators. Heterogeneity in the biology of 
adipose cells within the WAT has been reported to be linked to sex, ethnicity, age and 
location of body depots (e.g. visceral versus subcutaneous adipose tissue); these differences 
can be both structural and molecular (e.g. cytokine production) (Badimon and Cubedo, 2017, 
Tchkonia et al., 2013). It is not currently clear whether differences in mature WAT are 
mirrored by differences in the biological properties of their precursors. The more widely used 
source of WAT for stem cell research is the subcutaneous abdominal fat. 
 
The developmental origin of WAT is still largely unknown, however the advent of transgenic 
models, especially those with a Cre/Loxp-based tracing, has enormously helped to shade light 
on the embryological origin of WAT as well as the characterization of local progenitor cells 
within the adult organ, at least in animal models. The initial finding that peroxisome-
proliferation-activated receptor γ (PPARγ) expression is an early marker of adipocyte 
commitment, and that precursors are located in the mural compartment of the adipose tissue 
as PDGFβ (platelet-derived growth factor receptor β) -positive cells, paved the way for other 
studies aimed at localizing and determining the phenotype of adipose tissue progenitor cells 
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(Tran et al., 2012). An intriguing property underlying plasticity of WAT precursor is that they 
may be bi-potential and able to generate both adipose and endothelial cells, as the studies 
tracing the expression of zinc finger protein 423 (Gupta et al., 2010, Gupta et al., 2012) and 
VE-cadherin (Tran et al., 2012) have suggested; however other studies have contradicted 
these data (Berry and Rodeheffer, 2013). Embryologically, initial studies suggested that WAT 
originate from Myf5 (myogenic Factor 5)-negative precursors, unlike brown adipose tissue 
(BAT) and skeletal muscle which might share common Myf5-positive precursors (Seale et 
al., 2008, Timmons et al., 2007). However, it is now clear that some WAT cells can arise 
from Myf5-positive precursors. Lineage tracing using novel mouse models is shedding light 
on the high degree of complexity and heterogeneity of the developmental origin of WAT 
where different precursors may be recruited depending on the location of the fat depot 
(reviewed in (Sanchez-Gurmaches and Guertin, 2014). For example, in mice the anterior 
subcutaneous and retroperitoneal WAT (as well as BAT) likely derive from a mixed 
population of Myf5-positive and Myf5-negative precursors, though enriched in Myf5-positive 
cells, while inguinal and perigonadal WAT arise mostly from a Myf5-negative line.  
 
Intriguingly, analysis of abdominal WAT in humans who had received bone marrow stem 
cells (BM-MSCs) or mobilized peripheral blood stem cells transplants indicated the presence 
of donor-derived adipocytes, that are more likely derived from BM-MSCs than 
haematopoietic progenitors (Ryden et al., 2015). It is not clear, however, whether BM-MSCs 
contribute to the progenitor pool in the stromal fraction. Furthermore, given the ability of 
adipocytes to dedifferentiate in vitro (Matsumoto et al., 2008), it is also conceivable that some 
of the cells present in fat-derived cultures might be of BM origin. The plasticity observed in 
vitro might not be only a feature of cultured cells. It has been recently suggested that ADSCs 
can transdifferentiate in vivo when injected in the mammary gland and contribute to the 
growing ducts by acquiring an epithelial phenotype (De Matteis et al., 2009).   
 
Although WAT origin is still not well understood, discreet set of cell surface markers that 
selectively recognize WAT progenitors have been described, even though no single marker is 
widely accepted for their localization and/or isolation in vivo. A study identified a population 
(CD45-, CD31-, Lin-, CD29+, Sca1+, CD34+, CD24+) of progenitors that is able to regenerate 
WAT upon transplantation into lipodystrophic mice (Rodeheffer et al., 2008). However, 
depot- and even strain-specific differences in the presence and levels of expression of those 
cell surface markers have subsequently been reported (Joe et al., 2009, Macotela et al., 2012). 
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ADSCs have been extensively studied for their differentiation potential towards several 
lineages, both mesodermal and extra mesodermal. For example, we have described the high 
plasticity of ADSCs established from paediatric donors (pADSCs), and shown that selective 
skeletogenic differentiation is highly dependent on the induction medium (Guasti et al., 
2012). While there has been some indication that human ADSCs harbour also potential for 
myogenic differentiation (Desiderio et al., 2013, Stern-Straeter et al., 2014), we have been 
unable to unveil it in pADSCs using a variety of protocols including standard muscle 
differentiation protocols and small molecules; whether this reflects differences between adult 
and paediatric, or normal and patient-derived tissues, or differences in the experimental 
settings, remains to be elucidated. Nonetheless, pADSCs display significant plasticity, as they 
can easily undergo not only chondrogenic and osteogenic differentiation, but also differentiate 
towards neuroectodermal lineages. When exposed to a neural induction mediun containing 
valproic acid, pADCSs differentiate towards neuronal-like cells (Guasti et al., 2012, New et 
al., 2015). In addition, we have shown that they acquire an epithelial-like morphology when 
treated with retinoic acid (RA), a small lipophilic molecule that directs several differentiation 
processes during development and induces regeneration in several systems (Maden and Hind, 
2003). The occurrence of epithelial differentiation has been supported both by changes in 
gene and protein expression and by functional assays.  Formation of tight junctions, detected 
by selective translocation of Zona Occludens-1 (ZO1) protein to establish cell-to-cell 
contacts, and induction of cytokeratin 18 (CK18), that with K8 is expressed by simple 
epithelia at early developmental stages, was observed (New et al., 2017). In addition, that 
study showed the barrier forming potential of the epithelially–induced pADSCs. The 
epithelial differentiation capability of pADSC we have observed is consistent with both in 
vitro and in vivo studies showing the ability of adult ADSCs to generate epithelia of 
endodermal origin (like most airway epithelia), such as the urothelium (Baer, 2011, Li et al., 
2014). 
 
Significantly, the possibility of  differentiating and co-culturing pADSC-derived cartilage and 
epithelium can be valuable both for modeling human tissue interactions to investigate cellular 
and molecular mechanisms of disease as well as for “organ” engineering. ADSCs are amongst 
the most promising MSCs for clinical application in autologous reconstructive surgery as they 
can be easily harvested using minimally invasive techniques with extremely low morbidity, 
even from paediatric patients, as well as displaying immunomodulatory properties like MSC 
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from other sources. Hence pADCSs could potentially be harnessed in more complex 
translational settings, where both cartilaginous and epithelial tissues are required, such as for 
reconstructing deformities of the upper airways, including  those of the nose and throat. While 
discussion of pADCSs potential for tissue reconstruction in patients with craniofacial 
deformities is not within the scope of this article, it should be noted that selective 
differentiation of pADSCs to chondrocytes can also be achieved within novel bioscaffolds, 
which are cyto-compatible for tissue engineering applications, such as POSS-PCU 
(polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane) and POSS-PCL 
(polyhedral oligosilsesquioxane–poly(ε-caprolactone) (Griffin et al., 2017, Guasti et al., 
2014, New et al., 2017). 
 
Are pADSCs truly plastic? 
 
It has long been questioned whether somatic stem cells are indeed multipotent stem cells, or a 
heterogenous population of cells composed of subsets of unipotent progenitor cells. Some 
studies have supported the hypothesis that adult human ADSCs are multipotent stem cells, but 
one early study has suggested that not all clones possessed the ability to undergo trilineage 
differentiation (Guilak et al., 2006, Stillwell et al., 2012). Hence we carried out clonal 
analysis of pADSCs to test whether their apparent plasticity could be due to a fraction of the 
cell population endowed with multipotency or to different cells which can differentiate only 
into one or two lineages.  
 
Results and Discussion 
 
We isolated clones from ADSCs of a paediatric donor (male, age 16) by limiting dilution, 
with successful derivation of clones from 50% of visible single cells. The parent line 
displayed three-lineage differentiation potential (adipogenic, chondrogenic and osteogenic) as 
all the pADSC lines generated in our laboratory (>40) from paediatric patients (age range 7-
17 years).   
 
Previous studies had demonstrated expression of pluripotent markers in pADSCs and 
suggested that this may underlie their plasticity (Guasti et al., 2012, Park and Patel, 2010). In 
order to establish whether this pattern of expression was maintained in clonal lines, we 
assessed expression of KLF4 (KRUPPEL-LIKE FACTOR 4), OCT4 (OCTAMER-BINDING 
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PROTEIN 4, also known as POU domain, class 5, transcription factor 1, POU5F1) and 
NANOG (transcription factor named after Tìr nan Òg, the mythical Celtic land of youth) in 
the parental line, 3 clones and human embryonic stem cells (hESCs). As shown in Fig. 2, 
gene expression levels of OCT4 and NANOG were lower both in the parental pADSC line and 
in the clones, when compared to the levels found in hESCs, whereas KLF4 expression was 
considerably higher in pADSCs. No significant differences were observed in the expression 
levels of these factors between clones. A previous paper correlated the high expression of 
KLF4 with a more pluripotent phenotype, closer to that of an ESC. As well as an indicator of 
“stemness”, KLF4 regulates a number of different cellular processes including proliferation, 
differentiation and apoptosis. Interestingly, KLF4 was found to inhibit endodermal 
differentiation in murine ESCs (Aksoy et al., 2014). The high levels of KLF4 in pADSCs 
may play an important role in maintaining their undifferentiated status.   
 
In contrast to ESCs, parental pADSCs and clonal lines expressed high levels of GREM1 
(GREMLIN 1). GREM1 is a BMP (bone morphogenetic protein) antagonist that has been 
recently reported to identify clonogenic stem cell populations within the bone marrow and the 
intestine connective tissue in mice (Worthley et al., 2015). Expression of GREM1 in pADSC 
is consistent with self-renewal of these cells, as even lines maintained in culture over 20 
passages are still able to undergo multilineage differentiation, though their duplication time 
becomes a bit slower at around passage 10. 
 
Clones were then tested for their mesenchymal differentiation capability by treating them 
with adipogenic, chondrogenic and osteogenic induction media; as shown in Fig. 3 all clones 
were able to differentiate towards the three lineages, albeit with different efficiencies (Fig. 
3A-C). Together, though not all of the single cells were able to expand efficiently, those that 
did clearly possessed multilineage mesenchymal potential. This supports the existence, within 
the pADSC cultures, of cells with intrinsic plasticity towards mesodermal lineages. 
  
Having previously shown that pADSC can undergo non-mesodermal differentiation, we next 
investigated clonal line potential for epithelial and neuronal differentiation by comparing 
three clones and the parental line they were derived from. Following epithelial induction of 
pADSC clones (n=6), a general trend in up-regulation of the epithelial marker cytokeratin-18 
(CK18) was observed in all clones and the parental line at the transcriptional level (Figure 
4A). The tight junction marker, zonula occudens-1 (ZO-1), was unchanged upon epithelial 
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induction at a transcriptional level (not shown), but a clear translocation of ZO-1 from the 
cytoplasm to the plasma membrane after induction was noted in all the clones by 
immunocitochemistry (Figure 4B).  
 
Following induction of the clones with neurogenic media, a general trend in up-regulation of 
neural markers at the transcriptional level was noted (Figure 4C). The neuronal marker 
transcript, neuron-specific enolase (NSE), and the Schwann cell marker, P0, were increased in 
all clones, albeit to varying degrees and with some differences in their time-course. The 
neurogenic potential of the pADSC clones was also investigated at the protein level. Protein 
expression of the neuronal markers, NF-200 and MAP2 (Figure 4D), was assessed by 
immunofluorescence in pADSC clones. An increase in neural marker staining was obseved in 
all clones tested (n=5). Whereas induction of neural markers was clearly observed here and 
consistent with previous studies, we have no evidence that neurally induced cells, either from 
parental or clonal lines, can develop into mature neurons or glia. Both our previous work with 
a different type of MSCs, the amniotic fluid-derived stem cells, and studies of adult ADSC 
from other groups cast doubts on the possibility of inducing true neurogenic differentiation in 




Notwithstanding intense research in the field, much has yet to be understood about the in vivo 
behavior and tissue-specific properties of human MSCs. Endogenous MSCs are not able to 
spontaneously mount a significant regenerative response in humans and reconstruct skeletal 
critical size defects. The possibility of recruiting them following injury in a similar fashion to 
that observed in regenerating organs of fish and amphibians remains to date fairly remote. A 
more extensive knowledge of mechanisms governing regeneration in these systems as well as 
a better understanding of the biology of human endogenous MSCs in vivo will be needed to 
achieve this goal.  
 
Human MSCs display significant plasticity in vitro, that, at least in the case of ADSCs from 
young individuals, appears to reflect the existence of a multipotent stem cell population; to 
some extent this plasticity may also be expressed in vivo, as grafted MSCs can home and 
differentiate at sites different from those they originated from. For what MSC potential in 
replacing missing structures is concerned, in the medium term their therapeutic value seems to 
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lay mainly in their multilineage differentiation potential that can be harnessed for 
bioengineering different tissues.  
 
Importantly, there is evidence from in vitro studies and grafting experiments in animals, as 
well as from some clinical trials, that MSCs are endowed with significant modulatory 
properties that can reduce damage and possibly contribute to functional repair in some 
diseased tissues. 
 
In conclusion, these are indeed exciting times for human MSCs in the context of tissue 
damage and repair. 
 
 
Materials and Methods 
 
All chemicals were from Sigma-Aldrich, unless otherwise stated. 
 
Human Paediatric Adipose tissue-Derived Stem Cells  
Abdominal adipose tissue was aspirated from consenting paediatric patients under ethical 
approval from the Camden and Islington Community Local Research Ethics Committee 
(London, UK). pADSCs used in this study were isolated from a 16 year old male as 
previously described (Guasti et al., 2012, New et al., 2017) and cultured in high glucose 
DMEM (Dulbecco’s modified Eagle’s medium) with GlutaMAX™, supplemented with 10% 
ES-FBS (ES-qualified foetal bovine serum) and 1% penicillin/streptomycin. Cells were 
grown in humidified incubators at 37 °C with 5% CO2. 
 
Clonal Expansion 
pADCSs were detached from the flask with trypsin-EDTA, counted and plated at a density of 
0.8 cells/well in 96-well plates. Microscopic examination confirmed the presence or absence 
of single cells in wells. Medium was replaced twice a week, and when confluent, cells were 
amplified for experiments. 
 
Differentiation 
Differentiation was induced in clonal populations of pADSCs as previously described, by 
replacing the media with DMEM containing GlutaMAX™, 1% penicillin/streptomycin, 10% 
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ES-FBS supplemented with a specific cocktail for either the mesenchymal (adipogenic, 
osteogenic or chondrogenic), epithelial or neural lineages (Guasti et al., 2012, New et al., 
2015). The composition of the induction media used was as follow, 1) Adipogenic: DMEM 
10% embryonic stem cells-qualified (ES)-FBS, 10 ng/ml insulin, 500 µM 3-isobutyl-1-
methylxanthine, 1 µM dexamethasone, and 1 µM rosiglitazone (Molekula); 2) Chondrogenic: 
DMEM 10% ES-FBS, 0.1 µM dexamethasone, 10 ng/ml transforming growth factor (Tgf) β1 
(R&D Systems), insulin-transferrin-selenium (ITS) (Life Technologies), and 50 µg/ml 
ascorbate; 3) Osteogenic: DMEM 10% ES-FBS, 0.1 µM dexamethasone, 100 µg/ml 
ascorbate, and 10 mM β-glycerophosphate, 4) Neural: DMEM with Glutamax supplemented 
with 1% penicillin/streptomycin, 10% ES-FBS, 10 µM forskolin, 5 mM KCl, 2 mM valproic 
acid, 1 µm hydrocortisone and 5 µg/ml insulin (Huang et al., 2007); 4) Epithelial: DMEM 
10% ES-FBS 10% with Glutamax, 5µM retinoic acid (Brzoska et al., 2005). Cells were 
seeded onto Matrigel™-coated plates prior to epithelial differentiation.  
 
Mesenchymal lineages differentiation was assessed and quantified at 3 weeks as previously 
described, by staining with Oil Red O for adipogenic differentiation, Alizarin Red for 
osteogenic differentiation or Alcian blue for chondrogenic differentiation (Guasti et al., 
2012). For epithelial and neural differentiation, the cells were analyzed after the specified 
length of time for gene and protein expression. 
 
Reverse Transcription-Polymerase Chain Reaction and Quantitative Real-Time Polymerase 
Chain Reaction 
RNA was extracted from biological replicates using Tri-Reagent (Life Technologies) 
according to the manufacturer’s protocol and retro-transcribed with Moloney murine 
leukaemia virus reverse transcriptase (Promega). mRNA was quantified by real-time 
quantitative polymerase chain reaction using the Quantitect SYBR Green PCR kit (Qiagen) 
and the 7500-sequence detection system (Applied Biosysytems) following the manufacturer’s 
instructions. A list of the primers and their squences are specified in Supplemental Table 1. 
Expression levels were normalised using the house keeping gene, GAPDH. Fold changes ±SD 
were calculated taking either the control undifferentiated cells (differentiation experiments) or 
the parental line (pluripotency markers) as a reference. Statistical analysis was carried out by 





Cells were fixed in 4% PFA prior to immunofluorescence protein detection followed by 
washing multiple times with phosphate buffered saline (PBS), incubated with a 
blocking/permeabilizing buffer (10% FBS, 3% BSA, and 0.2% Triton-X100 in PBS) and then 
incubated overnight with the following primary antibodies: rabbit anti-ZO-1 (Life 
Technologies, 1:100 dilution in PBS), rabbit Anti NF-200 (Sigma, 1:200 dilution), mouse anti 
MAP2 (Life Technologies, 1:100 dilution). After washes, cells were incubated with 
secondary antibodies (Alexa Fluor 488 and 594, 1:400 dilution). Hoechst 33258 (2µg/ml, 
Sigma) was added during secondary antibody incubation to counterstain the cell nuclei. 
Negative controls were incubated with the secondary antibody and Hoechst 33258 only. 
Images were acquired with an inverted microscope Olympus IX71 (Carl Zeiss, Jena, 
Germany) equipped with a Hamamatsu ORCA-ER digital camera (Hamamatsu Corp., 
Bridgewater, NJ).  
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Fig. 1. In vivo and in vitro characteristics of MSCs. MSCs can be isolated from tissues of 
both adults and children, as well as from extra-embryonic tissues.  MSCs have been 
extensively studied for their in vitro ability to differentiate towards mesodermal lineages 
(adipocytes, chondrocytes and osteocytes), and specific protocols to generate cells of non-
mesodermal lineages have been developed. In vivo, MSCs’ most studied properties regard 
hematopoiesis regulation, the self-renewal of bone and cartilage and their potent 
immunoregulatory properties. The versatility typical of MSCs is being investigated for tissue 
regeneration purposes, either via their direct differentiation towards tissues to be engineered 
or by taking advantage of the actions of their secretome. 
 
Fig. 2. Expression of pluripotent and mesenchymal stem cell transcripts in pADSC 
parental line and clones as compared to hESCs. Expression was assessed by RT-qPCR. 
Note that expression of all genes is detected in parental line and clones, though NANOG and 
OCT4 at much lower levels, and KLF4 and GREM1 at higher levels than in hESCs. *: P<0.05. 
 
Fig. 3. Effect of induction of adipogenic, chondrogenic and osteogenic differentiation in 
three pADSC cloned lines. Fourteen clones obtained from a single donor were differentiated 
towards adipogenic, chondrogenic and osteogenic lineages for 21 days and then stained with 
Oil Red O (adipogenic), Alcian Blue (chondrogenic) and Alizarin Red (osteogenic) and 
quantified. As controls, cells were kept in non-inducing media for the same time. Mean ± 
SEM, triplicate biological samples per clone, differentiated samples in grey, controls in black. 
 
Fig. 4. Effect of induction of epithelial and neural differentiation in pADSC cloned lines 
as compared to the parental line.  A) RT-qPCR analysis of CK18 expression in 3 pADSC 
clones epithelially differentiated for 4 weeks. B) Representative image of expression and 
cellular localization of ZO-1 in a clone of pADSCs following epithelial differentiation 
induction (Epith) and in the undifferentiatiate control (Undiff). C) RT-qPCR analysis of  
neuronal (NSE) and glial (P0) marker expression in pADSCs after  2 weeks of neural 
induction. D) Representative image of NF-200 and MAP2 expression in a neuronally induced 




Table I. Comparative analysis of surface markers in 
of human UC-MSC, p-ADSC and NSC, by flow 
cytometry  
 
UC-MSC: umbilical cord mesenchymal stem cells, pADSC: 
paediatric adipose-tissue derived stem cells; NSC: neural 
stem cells (modified from New et al., 2015). 
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CD13! 97.48&±&1.4& 97.43&±&2.16& 82.07&±&9.53*&
CD29! 99.28&±&0.51& 98.70&±&1.15& 99.90&±&0.10&
CD44! 98.98&±&0.80& 99.87±&0.03& 99.83&±&0.06&
CD73! 98.28&±&1.01& 99.17&±&0.68& 99.47&±&0.33&
CD90! 98.95&±&0.85& 99.07&±&0.23& 67.13&±&24.65&
CD105! 99.00& 92.43&±&6.18& 57.20&
CD166! 97.00&±&1.55& 92.30&±&6.45& 99.50&±&0.15&
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Supplemental Table 1. Primers sequences 
Gene  Primers (5’-3’) 
CK18 For CACAGTCTGCTGAGGTTGGA 
Rev CAAGCTGGCCTTCAGATTTC 
GAPDH For TGATGACATCAAGAAGGTGGTGAAG 
Rev TCCTTGGAGGCCATGTGGGCCAT 
GREM1 For CAGCCTACACGGTGGGAGC 
Rev  CTGCTCTGAGTCATTGTGC 
KLF4 For CCCACACAGGTGAGAAACCT 
Rev TTCTGGCAGTGTGGGTCATA 
NANOG For GGATGGTCTCGATCTCCTGA 
Rev CCTCCCAATCCCAAACAATA 
NSE For CTGATGCTGGAGTTGGATGG 
Rev CCATTGATCACGTTGAAGGC 
OCT4 For GTACTCCTCGGTCCCTTTCC 
Rev CAAAAACCCTGGCACAAACT 
p0 For CCAGCTTTGCCCCTGTGGGT 
Rev AGTGTGCACGACGCTGAGCC      
SOX2 For CATGTCCCAGCACTACCAGA 
Rev GTCATTTGCTGTGGGTGATG 
 
 
	  
 
	  
